Wells Fargo Maintains Equal-Weight on Bristol-Myers Squibb, Raises Price Target to $60

Bristol-Myers Squibb Company -1.72%

Bristol-Myers Squibb Company

BMY

58.95

-1.72%

Wells Fargo analyst Mohit Bansal maintains Bristol-Myers Squibb (NYSE: BMY) with a Equal-Weight and raises the price target from $55 to $60.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via